Chondrosarcoma of the Pelvis
Keywords:
bone tumors, chondrosarcomas, pelvis, surgery.Abstract
Chondrosarcoma is a malignant tumor with hyaline chondroid differentiation that may associate myxoid changes, calcification, or ossification. The objective of this article is to describe an experience in the rehabilitative treatment of chondrosarcoma of the pelvis. A 69-year-old male patient is reported with diagnosis of differentiated chondrosarcoma in the left iliopubic branch. He underwent En bloc resection of the entire Enneking zone II + III and reconstruction with an inverted cone-type prosthesis. Rehabilitation treatment was prescribed. A multidisciplinary team is requires for the chondrosarcoma treatment. The patient evolved favorably with the rehabilitative treatment that included physiotherapy and occupational therapy techniques. The patient achieved independence for basic activities of daily living, autonomous transfers, and walking assisted with a walker. With the rehabilitation, an attempt was made to return the patient to the highest degree of functional capacity and independence possible.
Downloads
References
1. Melo GI, Martínez CV. Tumores óseos condroides: condromas versus condrosarcomas convencionales. Rev. Chil. Radiol. 2005;11(4). DOI:
http://dx.doi.org/10.4067/S0717-93082005000400005
2. Martínez-Tello FJ, Manjon-Luengo P, Montes-Moreno S. Condrosarcoma. Variantes de condrosarcoma. Rev Esp Patol. 2006;2(39):69-79. DOI: https://dx.doi.org/10.1016/S1699-8855(06)70016-2
3. Esparza-Romero R, Cortes-Torres EJ, García-Martínez D, Fuentes-Orozco C, Contreras Hernández GI, González-Ojeda A, Ramírez-Gonzales LR, Márquez-Valdez AR. Condrosarcomas óseos: Características clínicas y resultados quirúrgicos en 5 años. Rev Med Inst Mex Seguro Soc 2018 [acceso 12/02/2021];56(3)273-8. Disponible en: http://revistamedica.imss.gob.mx/editorial/index.php/revista_medica/rt/printerFriendly/840/2999
4. González Ramírez JA, Reyna González W, Rivera Doroteo A, Montalvo Ramírez PA. Condrosarcoma de esternón en paciente masculino de 58 años: reporte de caso. Rev. Fac. Med. Hum. 2020;20(3):502-6. DOI: https://doi.org/10.25176/RFMH.v20i3.2206
5. Murphey MD, Walter EA, Wilson AJ, Kransdort MJ, Temple HT, Gannon FH. From the archives of the AFIP: imaging of primary chondrosarcoma: radiologic- patologic correlation. Radiographics. 2003;23:1245-78. DOI:
https://doi.org/10.1148/rg.235035134
6. Nazeri E. Chondrosarcoma: An overview of clinical behavior, molecular mechanisms mediated drug resistance and potential therapeutic targets Critical Reviews in Oncology/Hematology 131 2018;102-9. DOI: https://10.1016/j.critrevonc.2018.09.001
7. Sakuraba M, Kimata Y, Lida H, Beppu Y, Chuman H, Kawai A. Pelvic ring reconstruction with the double-barreled vascularized fibular free flap. Plast Reconstr Surg. 2005;116:1340-5. Disponible en: DOI: https://doi.org/10.1097/01.prs.0000181736.85276.78
8. Dickey ID, Rose PS, Fuchs B, Wold LE, Okuno SH, Sim FH, et al. Dedifferentiated chondrosarcoma: the role of chemotherapy with updated outcomes. J Bone Joint Surg 2004 [acceso 12/02/2021];86:2412-8. Disponible en: https://pubmed.ncbi.nlm.nih.gov/15523011/
9. González-Pérez AM, Arvinius C, García-Coiradas J, García-Maroto R, Cebrian-Parra JL. Tratamiento quirúrgico de los tumores primarios malignos de pelvis de la zona II de Enneking. Acta Ortop. Mex. 2016;30(3):132-7. Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S2306-41022016000300132&lng=es
10. Liu C, Xi Y, Li M. Dedifferentiated chondrosarcoma: radiological features, prognostic factors and survival statistics in 23 patients, PloS One 2017;12(3):73665. DOI: https://doi.org/10.1371/journal.pone.0173665
11. Grimer RJ, Gosheger G, Taminiau A. Dedifferentiated chondrosarcoma: prognostic factors and outcome from a European group. Eur. J. Cancer 2007;43(14):2060-5. DOI: https://doi.org/10.1016/j.ejca.2007.06.016
12. Nie Z. Prognostic factors for patients with chondrosarcoma: A survival analysis based on the Surveillance, Epidemiology, and End Results (SEER) database (1973–2012) Journal of Bone Oncology 2018;13:55-61. DOI: http://doi.org/10.1016/j.jbo.2018.09.003
Download
